首页> 外国专利> Use of compounds capable of binding to glycoprotein gpIIb/IIIa for the prevention of restenosis

Use of compounds capable of binding to glycoprotein gpIIb/IIIa for the prevention of restenosis

机译:能够与糖蛋白gpIIb / IIIa结合的化合物在预防再狭窄中的用途

摘要

Platelet-specific, chimeric immunoglobulin and immunoglobulin fragments are described. The chimeric molecules are made up of a nonhuman antigen binding region and a human constant region. Preferred immunoglobulins are specific for glycoprotein IIb/IIIa receptor in its complexed form; they block ligand binding to the receptor and prevent platelet aggregation. The immunoglobulins can be used to reduce or prevent occlusion, reocclusion (e.g, abrupt closure), stenosis and/or restenosis. In addition, the immunoglobulins are useful in anti-thrombotic therapy when administered alone or in conjunction with thrombolytic agents, as well as in thrombus imaging.
机译:描述了血小板特异性的嵌合免疫球蛋白和免疫球蛋白片段。嵌合分子由非人抗原结合区和人恒定区组成。优选的免疫球蛋白以其复合形式对糖蛋白IIb / IIIa受体具有特异性。它们阻断配体与受体的结合并阻止血小板凝集。免疫球蛋白可用于减少或预防闭塞,再闭塞(例如突然闭合),狭窄和/或再狭窄。另外,当单独或与溶栓剂联合给药时,免疫球蛋白可用于抗血栓形成治疗,以及血栓显像。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号